Month: February 2021

GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses

Written by Customer Service on February 17, 2021. Posted in Public Companies.

– Companies applying their combined expertise in immunology and infectious diseases to accelerate the development of promising monoclonal antibody candidates for influenza –– Functional genomics collaboration expanded to include respiratory viruses, Vir’s unique technology, and access to GSK’s small molecule compounds –– Additional exploration of up to three other antibodies for pathogensbeyond influenza and coronaviruses –– GSK is increasing its equity investment by $120 million and making an upfrontpayment of $225 million –LONDON and SAN FRANCISCO, Feb. 17, 2021 (GLOBE NEWSWIRE) — GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced they have signed a binding agreement to expand their existing collaboration to include the research and development of new therapies for influenza and other...

Cementless Total Knee Arthroplasty Market 2021-2028, Size, Share, Growth, Trends, Analysis, Competitive Landscape, Revenue, Forecast Report

Written by Customer Service on February 17, 2021. Posted in Mergers And Acquisitions.

Pune, India, Feb. 17, 2021 (GLOBE NEWSWIRE) — The global Cementless Total Knee Arthroplasty Market size is anticipated to experience potential growth owing to the rising population of patients suffering with arthritis, observes Fortune Business Insights™ in an upcoming report, titled, “Cementless Total Knee Arthroplasty Market Size, Share & Industry Analysis, By Product Type (Mobile Bearing, Fixed Bearing), By End User (Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Others) and Regional Forecast, 2020-2027.” The procedure offers numerous benefits including minimum operating duration, elimination of the complications regarding cemented fixations, and ease in revision.The world of business has been introduced to a new set of adversities ever since it has been hit by the COVID-19 pandemic. Major economies of the world...

Royalty Pharma Reports Q4 2020 and Full-Year Results

Written by Customer Service on February 17, 2021. Posted in Earnings Releases And Operating Results.

Double-digit growth in Net cash provided by operating activities (GAAP) and Adjusted Cash Flow(2)$2.4 billion of acquisitions announced in 2020; maintained leading share of biopharma royalty funding marketIncreasing outlook for 2020-2025 Adjusted Cash Receipts(1)CAGR to 7%-10%NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the fourth quarter of 2020 and introduced full-year 2021 guidance for Adjusted Cash Receipts(1) (a non-GAAP financial measure).“Royalty Pharma achieved a number of major milestones in 2020,” said Pablo Legorreta, Royalty Pharma founder and Chief Executive Officer. “We strengthened our competitive positioning with our IPO and inaugural debt offering; we delivered strong growth in our business and maintained our leading share of biopharma royalty...

Tower Semiconductor Reports Double Digit Revenue Growth for the Fourth Quarter of 2020

Written by Customer Service on February 17, 2021. Posted in Earnings Releases And Operating Results.

Guides 15% Year Over Year Revenue Growth for the First Quarter of 2021;Expecting Quarterly Sequential Growth Throughout 2021Initiated 200mm and 300mm Capacity Expansion to Answer the Exceeding Demand ForecastMIGDAL HAEMEK, Israel, Feb. 17, 2021 (GLOBE NEWSWIRE) — Tower Semiconductor (NASDAQ: TSEM & TASE: TSEM) reported today its results for the fourth quarter and for the full year ended December 31, 2020.HighlightsFourth quarter revenues of $345 million, reflecting 11% quarter over quarter and 13% year over year growth.Organic revenue growth of 20% quarter over quarter and 17% year over year.Significant increases in the fourth quarter of 2020 in gross profit, operating profit, EBITDA and net profit, as compared to both prior quarter and the fourth quarter of 2019.Revenues for the full year 2020 of $1.266 billion, reflecting...

United Fire Group, Inc. Reports Fourth Quarter and Year End 2020 Results

Written by Customer Service on February 17, 2021. Posted in Earnings Releases And Operating Results.

CEDAR RAPIDS, Iowa, Feb. 17, 2021 (GLOBE NEWSWIRE) — United Fire Group, Inc. (Nasdaq: UFCS)Consolidated Financial Results – Highlights(1):United Fire Group, Inc. (the “Company” or “UFG”) (Nasdaq: UFCS) today reported consolidated net loss, including net realized investment gains, of $8.9 million ($0.36 per diluted share) for the three-month period ended December 31, 2020, compared to consolidated net loss of $23.2 million ($0.93 per diluted share) for the same period in 2019. For the year ended December 31, 2020, consolidated net loss, including investment losses, was $112.7 million ($4.50 per diluted share) compared to net income of $14.8 million ($0.58 per diluted share) for the same period in 2019.The Company reported a consolidated adjusted operating loss of $1.30 per diluted share for the fourth quarter 2020...

Humacyte, a Transformative Biotechnology Platform Company Capable of Manufacturing Universally Implantable Bioengineered Human Tissue at Commercial Scale, Going Public via Merger with Alpha Healthcare Acquisition Corp.

Written by Customer Service on February 17, 2021. Posted in Mergers And Acquisitions.

Humacyte aims to transform medicine with off-the-shelf, universally implantable, bioengineered human tissue available at commercial scale.Transaction values Humacyte at a pre-money valuation of $800 million with existing Humacyte shareholders rolling over 100% of their equity into equity of the Combined Company. Following transaction closing, Humacyte is expected to have a market capitalization of $1.1 billion.Transaction is expected to provide up to $255 million of cash proceeds, including a fully committed $175 million PIPE and up to $100 million of cash held in the AHAC trust account assuming no redemptions. As a result of outsized demand, the PIPE offering was oversubscribed and upsized.The PIPE was raised from a broad group of health care investors and thought leaders. These include Fresenius Medical Care, OrbiMed, Monashee Investment...

Silence Therapeutics Initiates Dosing in Phase 1 Clinical Trial of SLN360 for Cardiovascular Disease Due to High Lipoprotein(a)

Written by Customer Service on February 17, 2021. Posted in Public Companies.

Silence Therapeutics Initiates Dosing in Phase 1 Clinical Trial of SLN360 for Cardiovascular Disease Due to High Lipoprotein(a)17 February 2021LONDON, Silence Therapeutics plc, AIM: SLN and Nasdaq: SLN (“Silence” or “the Company”), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the treatment of diseases with significant unmet medical need, today announced that it has started dosing subjects in the APOLLO Phase I clinical study of its wholly owned lead product candidate, SLN360, for the treatment of elevated Lipoprotein (a) – or Lp(a) – levels.This first-in-human study is investigating the safety, tolerability, pharmacokinetic and pharmacodynamic response of SLN360 in people with elevated Lp(a) levels approximately ≥60 mg/dL. The APOLLO trial is a global, randomized,...

Lordstown Motors To Race Endurance Electric Pickup Truck Skateboard in San Felipe 250 Race in Baja California on April 17

Written by Customer Service on February 17, 2021. Posted in Public Companies.

LORDSTOWN, Ohio, Feb. 17, 2021 (GLOBE NEWSWIRE) — Lordstown Motors Corp. (Nasdaq: RIDE), (“Lordstown Motors”), a leader in electric light duty trucks focused on the commercial fleet market, has entered the Endurance Beta skateboard in the 2021 SCORE International San Felipe 250, part of the SCORE World Desert Championship race series. The 290-mile single loop race will start and finish in San Felipe, Baja California, Mexico on April 17, 2021.By taking the Endurance to the Mexican desert race course, which is considered one of the most grueling and punishing in the world, Lordstown Motors is setting out to prove that the Endurance is not only one of the safest, most efficient trucks on the planet, but also that it is the toughest, most robust as it tackles the San Felipe Desert.“We feel that it is quite a significant milestone for...

iTeos to Present at the 10th Annual SVB Leerink Global Healthcare Conference

Written by Customer Service on February 17, 2021. Posted in Public Companies.

CAMBRIDGE, Mass. and GOSSELIES, Belgium, Feb. 17, 2021 (GLOBE NEWSWIRE) — iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients, today announced that Michel Detheux, PhD, President and Chief Executive Officer, will host a fireside chat at the virtual 10th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 24, 2021 at 3:00 p.m. ET.A live webcast of the presentation will be available on the Investors section of the company’s website at https://www.iteostherapeutics.com. An archived replay will be available for approximately 30 days following the presentation.About iTeos Therapeutics, Inc.iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering...

Golden Tag Reports 175.30 m of 88.54 g/t Ag.Eq, 10% Grade Improvement Observed, From Infill Sampling at San Diego

Written by Customer Service on February 17, 2021. Posted in Public Companies.

TORONTO, Feb. 17, 2021 (GLOBE NEWSWIRE) — Golden Tag Resources Ltd. (“Golden Tag” or the “Company“) (TSX.V: GOG) (OTCQB: GTAGF) is pleased to provide initial results from the ongoing 4,500 metre (“m”) exploration program on the Company’s 100% owned San Diego Project, one of the largest undeveloped silver projects in Mexico. A program of infill sampling on historical diamond drill holes has advanced, results from two holes have significantly expanded the size of identified mineralized zones and in one of the holes, increased previously reported grades by 10%.Key highlights include:Infill sampling from historic hole SD-11-42 identified a significantly broader zone of mineralization, compared to the area originally sampled, including 175.30 metres of 88.54 g/t Ag.Eq. Four new mineralized zones were identified proximal to...

Month: February 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals